Free Trial

Cardinal Health, Inc. (NYSE:CAH) Raises Dividend to $0.51 Per Share

Cardinal Health logo with Medical background

Cardinal Health, Inc. (NYSE:CAH - Get Free Report) declared a quarterly dividend on Monday, May 5th, RTT News reports. Stockholders of record on Tuesday, July 1st will be given a dividend of 0.5107 per share on Tuesday, July 15th. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.38%. The ex-dividend date of this dividend is Tuesday, July 1st. This is a 1.0% increase from Cardinal Health's previous quarterly dividend of $0.51.

Cardinal Health has raised its dividend by an average of 1.0% annually over the last three years and has increased its dividend every year for the last 28 years. Cardinal Health has a dividend payout ratio of 22.5% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Cardinal Health to earn $8.95 per share next year, which means the company should continue to be able to cover its $2.02 annual dividend with an expected future payout ratio of 22.6%.

Cardinal Health Stock Down 3.7 %

CAH traded down $5.62 on Thursday, reaching $147.86. The company's stock had a trading volume of 2,549,095 shares, compared to its average volume of 2,549,055. The company has a market capitalization of $35.29 billion, a price-to-earnings ratio of 27.59, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $154.07. The stock has a 50 day moving average of $133.84 and a two-hundred day moving average of $125.81.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same period last year, the business earned $2.08 EPS. Cardinal Health's revenue for the quarter was up .0% compared to the same quarter last year. As a group, analysts anticipate that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on the company. Robert W. Baird lifted their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Morgan Stanley increased their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research note on Monday. Argus set a $148.00 price objective on shares of Cardinal Health in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research note on Tuesday, February 4th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $146.43.

Read Our Latest Stock Report on CAH

About Cardinal Health

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Articles

Dividend History for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines